Detalhe da pesquisa
1.
Subcutaneous trastuzumab with pertuzumab and docetaxel in HER2-positive metastatic breast cancer: Final analysis of MetaPHER, a phase IIIb single-arm safety study.
Breast Cancer Res Treat
; 187(2): 467-476, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33748921
2.
Outcome of multidisciplinary treatment in laryngeal cancer. Retrospective study with 10-years follow-up.
Cir Cir
; 88(4): 461-466, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32567606